INVO Bioscience (NASDAQ:INVO) Stock Price Down 3.9% – Should You Sell?

INVO Bioscience, Inc. (NASDAQ:INVO) shares were down 3.9% during mid-day trading on Wednesday . The company traded as low as $0.78 and last traded at $0.78. Approximately 25,997 shares changed hands during trading, a decline of 98% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.81.

INVO Bioscience Trading Up 1.4 %

The business’s 50-day moving average price is $0.86 and its 200-day moving average price is $0.83.

Hedge Funds Weigh In On INVO Bioscience

A hedge fund recently bought a new stake in INVO Bioscience stock. CWC Advisors LLC. purchased a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned 2.64% of INVO Bioscience at the end of the most recent reporting period. 12.02% of the stock is currently owned by hedge funds and other institutional investors.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.